DAAs are primarily used for the treatment of Hepatitis C in children. Chronic Hepatitis C, if left untreated, can lead to severe liver disease, including cirrhosis and liver cancer. The advent of DAAs has revolutionized the management of Hepatitis C in both adults and children, achieving high cure rates with shorter treatment durations and fewer side effects compared to older treatments, such as interferon and ribavirin.
